More Rhythm Biosciences Limited news
Rhythm Biosciences LimitedASX: RHY

S&P DJI Announces March 2022 Quarterly Rebalance

Mar 4, 2022 at 6:22 AM EST · Issued by Rhythm Biosciences Limited

Filed with ASX · Mar 4, 2022 at 6:22 AM EST · 10 pages · English

On 6ix: 6ix.com/news/sandp-dji-announces-march-2022-quarterly-rebalance-121

Rhythm Biosciences Limited on 6ix

Earlier from Rhythm Biosciences

  • Rhythm Biosciences - Investor Webinar PresentationMar 1, 2022
  • Appendix 4D and Half Yearly Report and AccountsFeb 24, 2022
  • Rhythm Maintains Ongoing ISO13485 CertificationFeb 14, 2022
  • Placement of $6.5m to Global Institutional Funds ManagerJan 5, 2022
  • RHY Platform Technology Targets Five CancersDec 13, 2021

Later from Rhythm Biosciences

  • Study 7 Confirms ColoSTAT Meets Primary EndpointApr 3, 2022
  • Rhythm Biosciences - Investor PresentationApr 4, 2022
  • Rhythm Biosciences: RHY Presentation at PAC Partners Healthcare ConferenceApr 5, 2022
  • Appendix 4C - quarterlyApr 27, 2022
  • Rhythm Closes Final Clinical Trial SiteMay 3, 2022
All Rhythm Biosciences news releases↗

Follow Rhythm Biosciences into a list and get an email when it puts out news.

Follow Rhythm Biosciences
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer